NASDAQ:CATB - Catabasis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$8.03 -0.07 (-0.86 %)
(As of 04/22/2019 12:19 PM ET)
Previous Close$8.10
Today's Range$8.03 - $8.12
52-Week Range$3.60 - $18.50
Volume400 shs
Average Volume200,744 shs
Market Capitalization$92.26 million
P/E RatioN/A
Dividend YieldN/A
Beta1.77

Analyst Ratings

Catabasis Pharmaceuticals (NASDAQ:CATB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Catabasis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $37.3333, suggesting that the stock has a possible upside of 364.92%. The high price target for CATB is $77.00 and the low price target for CATB is $15.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $37.3333$37.3333$40.6667$22.50
Price Target Upside: 364.92% upside410.02% upside651.69% upside224.35% upside

Catabasis Pharmaceuticals (NASDAQ:CATB) Consensus Price Target History

Price Target History for Catabasis Pharmaceuticals (NASDAQ:CATB)

Catabasis Pharmaceuticals (NASDAQ:CATB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/18/2019WedbushReiterated RatingBuy$20.00LowView Rating Details
1/14/2019OppenheimerBoost Price TargetOutperform$7.00 ➝ $77.00HighView Rating Details
8/10/2018CitigroupLower Price TargetBuy ➝ Buy$25.00 ➝ $15.00LowView Rating Details
10/6/2017CowenReiterated RatingMarket Perform$20.00N/AView Rating Details
10/5/2017CIBCReiterated RatingOutperform ➝ Outperform$40.00 ➝ $70.00N/AView Rating Details
8/14/2017HC WainwrightBoost Price TargetBuy$80.00 ➝ $90.00MediumView Rating Details
(Data available from 4/22/2017 forward)
This page was last updated on 4/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel